Your browser doesn't support javascript.
loading
A phase 1 study to evaluate the safety and pharmacokinetics of PQ912, a glutaminyl cyclase inhibitor, in healthy subjects.
Lues, Inge; Weber, Frank; Meyer, Antje; Bühring, Uli; Hoffmann, Torsten; Kühn-Wache, Kerstin; Manhart, Susanne; Heiser, Ulrich; Pokorny, Rolf; Chiesa, Joseph; Glund, Konrad.
Afiliação
  • Lues I; Probiodrug AG, Halle (Saale), Germany.
  • Weber F; Probiodrug AG, Halle (Saale), Germany.
  • Meyer A; Probiodrug AG, Halle (Saale), Germany.
  • Bühring U; Probiodrug AG, Halle (Saale), Germany.
  • Hoffmann T; Probiodrug AG, Halle (Saale), Germany.
  • Kühn-Wache K; Probiodrug AG, Halle (Saale), Germany.
  • Manhart S; Probiodrug AG, Halle (Saale), Germany.
  • Heiser U; Probiodrug AG, Halle (Saale), Germany.
  • Pokorny R; Covance Clinical Research Unit AG, Allschwil (Basel), Switzerland.
  • Chiesa J; Covance Clinical Research Unit Ltd, Leeds, UK.
  • Glund K; Probiodrug AG, Halle (Saale), Germany.
Alzheimers Dement (N Y) ; 1(3): 182-195, 2015 Nov.
Article em En | MEDLINE | ID: mdl-29854937
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2015 Tipo de documento: Article